Market Research Logo

Gastric Ulcers - Pipeline Review, H2 2018

Gastric Ulcers - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Ulcers - Pipeline Review, H2 2018, provides an overview of the Gastric Ulcers (Gastro


Introduction
Global Markets Direct Report Coverage
Gastric Ulcers - Overview
Gastric Ulcers - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Gastric Ulcers - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Gastric Ulcers - Companies Involved in Therapeutics Development
Boryung Pharmaceutical Co Ltd
Daewoong Pharmaceutical Co Ltd
Kukje Pharmaceutical Industry Co Ltd
RaQualia Pharma Inc
XuanZhu Pharma Co Ltd
Gastric Ulcers - Drug Profiles
(lafutidine + irsogladine maleate) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DWJ-1386 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DWP-14012 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KBP-3571 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KJ-14001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PMKS-005 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SFR-9X0123 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit COX-2 for Gastric Ulcers, Inflammation and Pain - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tegoprazan - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gastric Ulcers - Dormant Projects
Gastric Ulcers - Discontinued Products
Gastric Ulcers - Product Development Milestones
Featured News & Press Releases
Jul 17, 2013: Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
Mar 01, 2010: AstraZeneca Provides An Update On The Status Of Its Arrangements With Merck
Jan 07, 2010: AstraZeneca Reaches Agreements With Teva Pharmaceuticals Regarding Nexium And Prilosec US Patent Litigations
Apr 15, 2008: AstraZeneca Settles US Nexium Patent Litigation with Ranbaxy
Feb 28, 2008: AstraZeneca Provides An Update on the Status of its Arrangements With Merck & Co., Inc.
Dec 10, 2007: FDA Concludes There Is No Increased Risk Of Cardiac Events For Patients Treated With Omeprazole And NEXIUM (Esomeprazole Magnesium)
Jun 01, 2007: AstraZeneca’s Prilosec Patents Upheld By Court
Dec 12, 2003: Astrazeneca Prilosec Patents Upheld by Federal Appeals Court
Aug 08, 2003: Astrazeneca to Seek Triple Damages in Patent Infringement Lawsuit Against Mylan Pharmaceuticals
Oct 23, 2001: Prilosec US litigation
May 02, 2001: AstraZeneca Receives Six Months' Market Exclusivity for Prilosec
May 02, 2001: Court Denies Generic's Application for Summary Judgement on Prilosec Patent
Apr 23, 2001: AstraZeneca Files Lawsuit against Apotex Corporation and Torpharm for Patent Infringement
Dec 19, 2000: Astrazeneca Wins Losec Patent Litigation in Canada
Oct 20, 2000: Joint FDA Advisory Committee Confirms OTC Prilosec (Omeprazole) Safety and Efficacy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Gastric Ulcers, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Gastric Ulcers - Pipeline by Boryung Pharmaceutical Co Ltd, H2 2018
Gastric Ulcers - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2018
Gastric Ulcers - Pipeline by Kukje Pharmaceutical Industry Co Ltd, H2 2018
Gastric Ulcers - Pipeline by RaQualia Pharma Inc, H2 2018
Gastric Ulcers - Pipeline by XuanZhu Pharma Co Ltd, H2 2018
Gastric Ulcers - Dormant Projects, H2 2018
Gastric Ulcers - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Gastric Ulcers, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report